GSK Plc (GSK)
59.52
-1.33
(-2.19%)
USD |
NYSE |
Feb 20, 16:00
59.53
+0.01
(+0.02%)
After-Hours: 20:00
GSK SG&A Expense (Quarterly) : 3.510B for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| AstraZeneca PLC | 152.78M |
| Mereo BioPharma Group Plc | 6.007M |
| Novavax, Inc. | 31.66M |
| Biodexa Pharmaceuticals Plc | -- |
| AnaptysBio, Inc. | 10.21M |